{
    "clinical_study": {
        "@rank": "112801", 
        "arm_group": [
            {
                "arm_group_label": "Non-Pathologic Adults age 18-28 yrs"
            }, 
            {
                "arm_group_label": "Non-Pathologic Adults age 29-80 yrs"
            }, 
            {
                "arm_group_label": "Pathologic Adults age 29-80 yrs"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of this clinical study is to collect clinical data to support an FDA\n      510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to\n      evaluate any adverse events found during the clinical study."
        }, 
        "brief_title": "Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Corneal Endothelial Cell Loss", 
        "condition_browse": {
            "mesh_term": "Corneal Endothelial Cell Loss"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria \uff0dNon-Pathologic Young Adults (18-28 years old) and Non-Pathologic\n        Adults (29-80 years old):\n\n          -  Male or female subjects from 18 to 80 years old who have full legal capacity to\n             volunteer on the date the informed consent is signed;\n\n          -  Subjects who can follow the instructions by the clinical staff at the clinical site,\n             and can attend examinations on the scheduled examination date;\n\n          -  Subjects who agree to participate in the study.\n\n        Inclusion Criteria \uff0dPathologic Adults (29-80 years old)\n\n          -  Male and female subjects from 29 to 80 years old who have full legal capacity to\n             volunteer on the date the informed consent is signed;\n\n          -  Subjects who can follow the instructions by the clinical staff at the clinical site,\n             and can attend examinations on the scheduled examination date;\n\n          -  Subjects who agree to participate in the study;\n\n          -  At least one eye with any of the following conditions:\n\n               -  History of post-op surgical trauma including Pseudophakic or Aphakic bullous\n                  keratopathy;\n\n               -  History of corneal transplant;\n\n               -  Physical injury or trauma to the cornea;\n\n               -  Long term Fuch's dystrophy/Guttata (and other corneal endothelial dystrophies)\n\n               -  Keratoconus;\n\n               -  Long term PMMA contact lens use (greater than 3 years).\n\n        Exclusion Criteria \uff0dNon-Pathologic Young Adults (18-28 years old) and Non Pathologic\n        Adults (29-80 years old)\n\n          -  History of corneal transplant;\n\n          -  Long term Fuch's dystrophy (and other corneal endothelial dystrophies);\n\n          -  Keratoconus;\n\n          -  Guttata;\n\n          -  Diabetes mellitus type I or type II;\n\n          -  History of cataract, refractive or ocular surgical procedures that render the cornea\n             opaque or otherwise impact its ability to be imaged using the investigational device;\n\n          -  All contact lens wearers;\n\n          -  Fixation problems which may prevent obtaining good quality SP-1P and CELLCHEK PLUS in\n             either eye.\n\n        Exclusion Criteria \uff0dPathologic Adults (29-80 years old):\n\n          -  Fixation problems which may prevent obtaining at least poor quality (refer to Figure\n             1) SP-1P and KONAN CELLCHEK PLUS images in either eye."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Ophthalmology Practice"
            }
        }, 
        "enrollment": {
            "#text": "65", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02138266", 
            "org_study_id": "TOPCON-SP-1P-US-0001"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Non-Pathologic Adults age 18-28 yrs", 
                    "Non-Pathologic Adults age 29-80 yrs", 
                    "Pathologic Adults age 29-80 yrs"
                ], 
                "intervention_name": "Topcon Specular Microscope SP-1P", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Non-Pathologic Adults age 18-28 yrs", 
                    "Non-Pathologic Adults age 29-80 yrs", 
                    "Pathologic Adults age 29-80 yrs"
                ], 
                "intervention_name": "Konan Specular Microscope CELLCHEK XL", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Andover", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "01810"
                }, 
                "name": "Andover Eye Associates"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Comparative Study of the Topcon Specular Microscope SP-1P and the Konan Specular Microscope CELLCHEK XL (Predicate Device) for the Measurements of Endothelial Cell Density Measurements, Coefficient of Variation of Endothelial Cell Area, \uff05 Hexagonality, Central Corneal Thickness", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Corneal endothelial cell density", 
                "safety_issue": "No", 
                "time_frame": "Single time point - 1 day"
            }, 
            {
                "measure": "Coefficient of variation of endothelial cell area", 
                "safety_issue": "No", 
                "time_frame": "Single time point - 1 day"
            }, 
            {
                "measure": "Corneal endothelial cell % hexagonality", 
                "safety_issue": "No", 
                "time_frame": "Single time point - 1 day"
            }, 
            {
                "measure": "Central corneal thickness", 
                "safety_issue": "No", 
                "time_frame": "Single time point - 1 day"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02138266"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Topcon Medical Systems, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Topcon Medical Systems, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}